Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,769,995
+$44,837 QoQ
Shares Held
11,294
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#460
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenwich Wealth Management LLC holds $17,338,236 across 10 Drug Manufacturers - General names. NVS ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,267 | $3,590,147 | |
| 2 | PFE |
Pfizer Inc
|
140,297 | $3,378,351 | |
| 3 | LLY |
ELI LILLY & Co
|
2,759 | $3,309,227 | |
| 4 | NVS |
Novartis AG
This page
|
11,294 | $1,769,995 | |
| 5 | GSK |
GSK plc
|
31,884 | $1,671,359 | |
| 6 | JNJ |
Johnson & Johnson
|
4,468 | $1,134,737 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,081 | $909,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,467 | $817,040 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,769,995 | 11,294 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,725,158 | 11,294 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,559,585 | 11,312 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,450,650 | 11,312 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,368,865 | 11,312 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,270,872 | 11,400 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,204,503 | 12,378 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,348,609 | 11,725 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,221,734 | 11,476 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,110,073 | 11,476 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,158,731 | 11,476 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,168,945 | 11,476 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,158,043 | 11,476 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,055,792 | 11,476 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,041,102 | 11,476 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $872,290 | 11,476 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $970,066 | 11,476 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,007,019 | 11,476 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,012,115 | 11,571 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $931,147 | 11,386 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,030,190 | 11,291 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $965,154 | 11,291 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,066,209 | 11,291 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $981,865 | 11,291 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $986,155 | 11,291 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $930,942 | 11,291 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||